ArticleCancer cell international2026
Joint segmentation and classification of cervical cells using U-Net and CNN ensemble for early detection of cervical cancer.
Article in Cancer cell international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer remains a leading cause of mortality among women, particularly in resource-limited settings where cytological screening is hindered by manual analysis challenges. This study presents a joint segmentation and classification framework integrating U-Net and a CNN ensemble to automate and enhance the accuracy of cervical cell analysis. The U-Net architecture is employed to delineate nuclei and cytoplasmic boundaries from Pap smear images, leveraging skip connections to preserve spatial resolution in complex cellular environments. Following segmentation, an ensemble classifier combining ResNet-50, VGG-16, and InceptionV3 is utilised to differentiate cervical cell types with high precision. The proposed method was evaluated on benchmark datasets (APACS-23, Cx22, SIPaKMeD) using stratified five-fold cross-validation and external validation cohorts. Experimental results achieved a mean Dice coefficient of 0.934 for segmentation and a classification accuracy of 94.6%, outperforming single-model baselines by 5–8% in F1-score and AUC metrics. Grad-CAM visualisations demonstrated that the model’s focus corresponded to diagnostically relevant regions, reinforcing clinical interpretability. Ablation studies confirmed that the joint learning architecture substantially enhanced feature localisation and classification robustness. This research contributes a deployable, interpretable AI-based pipeline suitable for real-time cervical cancer screening, offering potential deployment in both centralised laboratories and low-resource healthcare environments. Future directions include expanding dataset diversity, integrating transformer-based models, and developing lightweight implementations for edge devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.